Efficiency of Remaxol Use in Supporting Treatment of Advanced Tuberculosis

Efficiency of Remaxol Use in Supporting Treatment of Advanced Tuberculosis

The aim of this study was to evaluate effectiveness of remaxol inclusion in the supporting therapy regimen in patients with the fibrous-cavernous form of drug-resistant tuberculosis. Treatment of 173 patients with fibrous-cavernous pulmonary tuberculosis was analyzed. Standard clinical laboratory me...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Kolomiets, A. L. Kovalenko, E. V. Talikova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	fibrous-cavernous pulmonary tuberculosis anti-tuberculosis therapy remaxol adherence to treatment supporting treatment
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/141
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The eﬀectiveness of psychological support with the use of hepato-immunoprotectors as predictors in drug therapy of tuberculosis
by: V. M. Kolomiets, et al.
Published: (2021-08-01)

Accompanying Immunomodulatory Therapy in Treatment of Patients with Neglected Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Predictors of the Effectiveness of Psychological Support in Addition to the Base Treatment in Pulmonary Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2024-01-01)

The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
by: V. M. Kolomiets, et al.
Published: (2020-12-01)

A Clinical Case of the Personalized Approach to Surgical Treatment of Drug-Resistant Bilateral Fibrous Cavernous Pulmonary Tuberculosis Complicated by Pyopneumothorax and Pleural Cavity Empyema
by: G. G. Kudryashov, et al.
Published: (2022-04-01)

Immediate results of lung resections in patients with fibrous cavernous tuberculosis
by: D. E. Omelchuk, et al.
Published: (2019-05-01)

Analysis of efficacy of lung resections and pneumonectomies in patients with fibrous cavernous tuberculosis depending on disease activity
by: D. E. Omelchuk, et al.
Published: (2019-09-01)

Remaxol Hepatoprotective Therapy of Patients with Tuberculosis and HIV Infection in Day Unit of Tuberculosis Dispensary
by: E. V. Shevyreva, et al.
Published: (2020-05-01)

Investigation of Remaxol Efficacy in Complex Therapy of Experimental Generalized Tuberculosis on Mice
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

INDIVIDUAL NUTRITIONAL SUPPORT FOR PULMONARY TUBERCULOSIS PATIENTS AT VARIOUS STAGES OF SURGICAL TREATMENT
by: M. V. Lukianova, et al.
Published: (2016-10-01)

Comorbid Tuberculosis in the Context of the Formation of a Local Epidemic Situation
by: V. M. Kolomiets, et al.
Published: (2025-02-01)

The structure of intra- and postoperative complications after surgery for fibrous-cavernous pulmonary tuberculosis and their impact on the surgery outcome
by: D. E. Omelchuk, et al.
Published: (2022-05-01)

Staged Surgical Treatment of Patients with Destructive Pulmonary Tuberculosis with pre-XDR Using Anterior Mediastinal Plasty
by: R. V. Tarasov, et al.
Published: (2023-01-01)

Some Peculiarities of Modern Comorbid Tuberculosis Therapy
by: V. M. Kolomiets, et al.
Published: (2023-02-01)

Comprehensive Treatment of Disseminated Fibrous Cavernous Pulmonary Tuberculosis with Extrapleural Thoracoplasty by Mesh Implant
by: S. A. Belov, et al.
Published: (2023-08-01)

A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance
by: P. N. Golubchikov, et al.
Published: (2020-07-01)

Immunophenotype of the macrophage population in fibrous, cavernous pulmonary tuberculosis
by: E. P. Golubinskaya, et al.
Published: (2019-05-01)

Application of Hepatoprotector Remaxol in the Treatment of Patients Co-Infected with Tuberculosis, HIV, and Chronic Hepatitis C
by: YU. G. Pritulina, et al.
Published: (2020-05-01)

Impact of Multiple Drug Resistant Tuberculous Mycobacteria on the Outcomes of Lung Resection for Fibrous Cavernous Tuberculosis
by: D. E. Omelchuk, et al.
Published: (2023-03-01)

EFFICACY OF REMAXOL AND ADEMETHIONINE IN EXPERIMENTAL LIVER DAMAGE CAUSED BY A COMBINATION OF RESERVE-SERIES ANTITUBERCULOSIS DRUGS AND ALCOHOL
by: D. S. Sukhanov, et al.
Published: (2014-04-01)

Therapy and Rehabilitation of Patients with Pulmonary Tuberculosis and Different Treatment Adherence
by: N. V. Rubleva, et al.
Published: (2020-05-01)

Factors Associated with Tuberculosis Relapses Development
by: A. A. Abilbayeva, et al.
Published: (2022-11-01)

Endobronchial valve in complex treatment of patients with drug resistant fibrous cavernous pulmonary tuberculosis
by: O. Yu. Askalonova, et al.
Published: (2020-02-01)

Evaluating Adherence to Medication among Tuberculosis Patients
by: Komal Kapoor, et al.
Published: (2025-03-01)

Problem of treatment adherence in tuberculosis patients
by: A. V. Belostotsky, et al.
Published: (2015-04-01)

Methodology of the Treatment of Pulmonary Tuberculosis
by: Frayt V., et al.
Published: (2013-03-01)

Treatment adherence and its association with family support among pulmonary tuberculosis patients in Jinja, Eastern Uganda
by: Businge Alinaitwe, et al.
Published: (2025-04-01)

Psychological support in the formation of adherence to the treatment of patients with tuberculosis
by: P. A. Maier, et al.
Published: (2024-04-01)

Development and validation of a digital health application to support tuberculosis treatment adherence
by: C. Andrade-Sales, et al.
Published: (2025-07-01)

What are the reasons for patients not adhering to their anti-TB treatment in a South African district hospital?
by: Somasundran Govender, et al.
Published: (2009-12-01)

DRUG-INDUCED LIVER LESIONS AND THEIR MANAGEMENT IN THE MANIFESTATIONS OF TUBERCULOSIS
by: A. V. Mordyk, et al.
Published: (2015-09-01)

Pharmacist-led education intervention to improve pulmonary tuberculosis treatment adherence through the Health Belief Model in Malaysia: a study protocol for a randomized controlled trial
by: Rabbiya Ahmad, et al.
Published: (2025-06-01)

Endobronchial valve block in the treatment of patients with destructive pulmonary tuberculosis and low adherence to therapy with anti-tuberculosis drugs and refusing to stay in hospital
by: P. A. Fadeev, et al.
Published: (2020-01-01)

A Unique Case of Cure of the Patient with Disseminated Bilateral Fibrous Cavernous Pulmonary Tuberculosis with Extensive Drug Resistance after 18 Years of Treatment Failures
by: O. G. Komissarova, et al.
Published: (2024-12-01)

REMAXOL: MECHANISMS OF ACTION AND APPLICATION IN REAL CLINICAL PRACTICE
by: L. Yu. Ilchenko, et al.
Published: (2016-05-01)

Treatment Adherence and Outcomes in Patients with Tuberculosis Treated with Telemedicine: A Scoping Review
by: Kikelomo Sabainah Olowoyo, et al.
Published: (2025-03-01)

The Problem of Comorbid Socially Significant Infections Under The Conditions of The COVID-19 Pandemic
by: V. M. KOLOMIETS, et al.
Published: (2022-11-01)

DELAYED OUTCOMES OF SURGICAL TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS RESIDING IN THE REGION WITH HIGH PREVALENCE OF THE DISEASE
by: M. V. Reykhrud, et al.
Published: (2017-02-01)

Remaxol in Correction of Functional Hepatic Failure in Patients with Acute Biliary Pancreatitis
by: A. P. Vlasov, et al.
Published: (2020-05-01)

MULTIPLE DRUG RESISTANCE PROTEINS OF PULMONARY SOMATIC CELLS AND THEIR SPECIFIC EXPRESSION IN FIBROUS CAVERNOUS TUBERCULOSIS
by: M. V. Erokhina, et al.
Published: (2016-09-01)